Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
39.55
-1.68 (-4.07%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Structure Therapeutics Employees
Structure Therapeutics had 281 employees as of June 30, 2026. The number of employees increased by 82 or 41.21% compared to the same quarter last year.
Employees
281
Change
82
Growth
41.21%
Revenue / Employee
n/a
Profits / Employee
-$764,537
Market Cap
2.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 281 | 82 | 41.21% |
| Mar 31, 2026 | 233 | 50 | 27.32% |
| Dec 31, 2025 | 220 | 57 | 34.97% |
| Sep 30, 2025 | 218 | 70 | 47.30% |
| Jun 30, 2025 | 199 | 63 | 46.32% |
| Mar 31, 2025 | 183 | 72 | 64.86% |
| Dec 31, 2024 | 163 | 70 | 75.27% |
| Sep 30, 2024 | 148 | 61 | 70.11% |
| Jun 30, 2024 | 136 | 59 | 76.62% |
| Mar 31, 2024 | 111 | 43 | 63.24% |
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Sep 30, 2023 | 87 | 15 | 20.83% |
| Jun 30, 2023 | 77 | 5 | 6.94% |
| Mar 31, 2023 | 68 | - | - |
| Dec 31, 2022 | 68 | - | - |
| Sep 30, 2022 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Arcutis Biotherapeutics | 354 |
| Nurix Therapeutics | 317 |
| Immunome | 247 |
| uniQure | 221 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 165 |
| NewAmsterdam Pharma Company | 100 |
GPCR News
- 15 hours ago - Structure Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 2 days ago - Structure weakness ‘disconnected’ from underlying data, says Jefferies - TheFly
- 2 days ago - Structure obesity portfolio updates ‘encouraging,’ says Clear Street - TheFly
- 2 days ago - Structure Therapeutics reports ACCG-2671, aleniglipron trial results - TheFly
- 2 days ago - Structure Therapeutics Transcript: Study result - Transcripts
- 2 days ago - Structure Therapeutics Press release: Study result - Filings
- 2 days ago - Structure Therapeutics Slides: Study result - Filings
- 2 days ago - Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management - GlobeNewsWire